$GRX

Saba Capital Management, L.P. purchased $59K of GRX (indirect holdings)

Saba Capital Management, L.P. purchased 6,220 indirectly-held shares of Gabelli Healthcare & WellnessRx Trust (GRX) at an average of $9.41 ($9.35–$9.41) across 2 trades over 2026-10-01 to 2026-10-02.

Original reporting
SEC EDGAR · Saba Capital Management, L.P.
Published Oct 5, 2026, 2:57 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 3:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GRX
Neutral
low confidence
Mentioned
$GRX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GRXNeutralLow
01

Why it matters

The purchase is a primary disclosure but its materiality is low due to the small dollar amount.

02

Market read

Limited relevance; the filing provides a minor data point for investors monitoring insider activity in GRX.

03

What to watch

The trust's underlying holdings could be impacted by sector news, but the Form 4 itself adds no new fundamental information.

Relevance 4/10Novelty 3/10Timing: today (filing date 2026-10-05)

Background

SEC Form 4 filings disclose insider transactions. Saba Capital Management is listed as a 10% owner of the trust.

Company-level read

Ticker impact

$GRXNeutralLow confidence
Context

Saba Capital Management purchased 6,220 shares of the Gabelli Healthcare & WellnessRx Trust (GRX) for $58,500, increasing its holding to 2,162,772 shares.

Expected impact

slight upward pressure as the market prices the insider buy

Evidence & confidence

The transaction is under $100k and represents a tiny fraction of the trust's float, limiting any material price effect.

Market effects

None; the trust holds a basket of healthcare securities and the small purchase does not affect the broader sector.

None; the filing is specific to the trust and does not influence regional markets.

Minimal; limited to investors tracking insider activity in GRX.

Counterpoint

Given the tiny size of the purchase, it may be a routine portfolio adjustment rather than a bullish signal.

Key entities

  • Saba Capital Management, L.P.

    Institutional investor and 10% owner of the trust.

  • Gabelli Healthcare & WellnessRx Trust

    Publicly traded trust (ticker GRX) holding healthcare and wellness assets.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LWAYLow

Divisadero Street Capital Management, LP (Zolezzi William) purchased $2.2M of LWAY (indirect holdings)

Divisadero Street Capital Management, LP purchased 103,684 indirectly-held shares of Lifeway Foods, Inc. (LWAY) at an average of $20.92 ($20.80–$21.09, $2.17M total) across 3 trades over 2026-10-02 to 2026-10-06. Filed jointly with Divisadero Street Partners GP, LLC (10% owner), Zolezzi William (10% owner), Divisadero Street Partners, L.P. (10% owner) and Divisadero Street Capital, LLC (10% owner).